3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
30
Breast Neoplasms
19
Neoplasms
13
Prostatic Neoplasms
10
Obesity
6
Colorectal Neoplasms
6
Sarcopenia
5
Pancreatic Neoplasms
5
Lung Neoplasms
4
Signs and Symptoms
3
Polycystic Ovary Syndrome
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Head and Neck Neoplasms
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Cachexia
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Interventions
fludarabine
5
Cyclophosphamide
5
Cyclosporine
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Imatinib Mesylate
3
Therapeutics
2
Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Methotrexate
2
Hematologic Tests
2
Busulfan
2
Antilymphocyte Serum
2
thymoglobulin
1
nilotinib
1
bosutinib
1
Urinalysis
1
Transplantation, Homologous
1
Tetanus Toxoid
1
Standard of Care
1
Resistance Training
1
Registries
1
Radiotherapy
1
Pharmaceutical Services
1
Ondansetron
1
Nurse Clinicians
1
Modafinil
1
Melphalan
1
Health Promotion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Resistance Training
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled